Who is sponsoring NCT04338542?

NCT04338542 is sponsored by Sara De Dosso.

What drugs are being tested in NCT04338542?

Interventions in NCT04338542: Tumor biobsies analysis.

What condition does NCT04338542 study?

NCT04338542 studies Mestastatic ColoRectal Cancer.

Is NCT04338542 still recruiting?

NCT04338542 is currently completed. Last updated 11 August 2020.

Last reviewed 2020-08-11 · How we verify

NCT04338542

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Retrospective Study Project of Clinico-molecular Characterization in Patients With Metastatic Colorectal Cancer

Completed Last updated 11 August 2020

What this trial tests

trial testing Tumor biobsies analysis in Mestastatic ColoRectal Cancer in 45 participants. Completed in 2 July 2020.

Timeline

8 April 2020

Primary endpoint
2 July 2020

2 July 2020

Quick facts

Lead sponsor	Sara De Dosso
Status	Completed
Study type	OBSERVATIONAL
Enrollment	45
Start date	8 April 2020
Primary completion	2 July 2020
Estimated completion	2 July 2020
Sites	1 location across Switzerland

Drugs / interventions tested

Tumor biobsies analysis

Conditions studied

Mestastatic ColoRectal Cancer — all drugs for Mestastatic ColoRectal Cancer →

Sponsor

Sara De Dosso

Who can join

18 and older, any sex, with Mestastatic ColoRectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective, translational, proof-of-concept study on tumor biopsies done on patients affected by mCRC and exhibiting RAS mutation. For each patient it will be selected the tissue biopsies of primary tumour and of paired resected metastasis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04338542 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sara De Dosso
Last refreshed: 11 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04338542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing